A Phase II Study of Capecitabine Combined with Gemcitabine in Patients with Advanced Gallbladder Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Phase II Study of Capecitabine Combined with Gemcitabine in Patients with Advanced Gallbladder Carcinoma

Published:2005 Issue:4 Volume:46 Page:526
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Cho Jae-Yong¹,Nam Ji-Sun¹,Park Mi-Suk²,Yu Jeong-Sik²,Paik Yong-Han¹,Lee Se-Joon¹,Lee Dong-Ki¹,Yoon Dong-Sup³

Affiliation:

1. Department of Internal Medicine, Yongdong Severance Hospital Pancreatobiliary Clinic, Yonsei University College of Medicine, Seoul, Korea.

2. Department of Diagnostic Radiology, Yongdong Severance Hospital Pancreatobiliary Clinic, Yonsei University College of Medicine, Seoul, Korea.

3. Department of Surgery, Yongdong Severance Hospital Pancreatobiliary Clinic, Yonsei University College of Medicine, Seoul, Korea.

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3349/ymj.2005.46.4.526

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2021-07

2. Systemic therapy of gallbladder cancer: review of first line, maintenance, neoadjuvant and second line therapy specific to gallbladder cancer;Chinese Clinical Oncology;2019-08

3. Retrospective comparative study between gemcitabine/cisplatin and gemcitabine/capecitabine in the treatment of metastatic carcinoma of gallbladder;Clinical Cancer Investigation Journal;2018

4. Targeted therapy in biliary tract cancers—current limitations and potentials in the future;Journal of Gastrointestinal Oncology;2017-04

5. Comparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study;Journal of Gastrointestinal Cancer;2016-10-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3